Airway inflammation in symptomatic and asymptomatic subjects with and without airway hyperresponsiveness

D. F. Jansen, D. S. Postma, B. Rutgers, J. Kraan, W. Timens (Groningen, The Netherlands)

Source: Annual Congress 2001 - Inflammatory mechanisms of COPD
Session: Inflammatory mechanisms of COPD
Session type: Oral Presentation
Number: 2112
Disease area: Airway diseases

Congress or journal article abstract

Abstract

Background: Inflammation in the airways plays an important role in asthma and COPD. It is unclear whether this also plays a role in asymptomatic subjects with airway hyperresponsiveness (AHR). Aim: In a sample from a general adult population we determined whether airway inflammation was related to chronic respiratory symptoms and/or AHR (PC20 [lte] 8 mg/ml histamine), and other characteristics including atopy, blood eosinophilia and smoking habits. Methods: Bronchial biopsies were obtained from 14 symptomatic subjects with AHR, 12 symptomatic subjects without AHR, 12 asymptomatic subjects with AHR, and from 19 asymptomatic subjects without AHR. Airway inflammation and vascular adhesion molecules were assessed by immunostaining (CD3, CD4, CD8, MBP, EG2, AA1, NP57, CD68, CD20/22, CD25, and CD54, CD106, CD62E combined with CD31 antibodies). Results: There was no difference in inflammation between the four groups. A new finding is the lower number of macrophages in symptomatic atopic individuals (median= 35.5, range=20-84) than in non-atopic (68, 13-220) or asymptomatic atopic individuals (67.5, 26-127). More CD8+ T-cells were observed in smokers (62.5, 13-153) than in never smokers (47, 1-94), and more eosinophils in subjects with blood eosinophilia (4, 0-30) than in subjects without blood eosinophilia (1, 0-22). Discussion: The inflammatory mechanisms in atopic symptomatic subjects may indirectly downregulate the number of macrophages. Eosinophilia in asymptomatic subjects with AHR may indicate a heightened immune response capable of activating the eosinophils in the bronchial wall.


Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
D. F. Jansen, D. S. Postma, B. Rutgers, J. Kraan, W. Timens (Groningen, The Netherlands). Airway inflammation in symptomatic and asymptomatic subjects with and without airway hyperresponsiveness. Eur Respir J 2001; 16: Suppl. 31, 2112

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Airway inflammation and airway pathophysiology in older asthmatics
Source: Annual Congress 2011 - New mechanisms in airway disease
Year: 2011

Analysis of airway inflammation in allergic subjects with asymptomatic increased airway response to methacholine
Source: Eur Respir J 2006; 28: Suppl. 50, 678s
Year: 2006

Sputum eosinophilia, airway hyperresponsiveness and airway narrowing in young adults with former asthma
Source: Eur Respir J 2005; 26: Suppl. 49, 733s
Year: 2005

Bronchial reversibility and airway inflammation in patients with COPD
Source: Eur Respir J 2003; 22: Suppl. 45, 436s
Year: 2003

Airway inflammation and upper airway infection in asthmatic children
Source: Annual Congress 2008 - Assessment of inflammation, hyperresponsiveness and response to exercise in asthmatic children
Year: 2008

Allergen-induced nonspecific bronchial hyperresponsiveness in patients with intermittent asthma
Source: Annual Congress 2009 - Airway hyperresponsiveness: mechanism and assessment
Year: 2009

Correlation between bronchial hyperresponsiveness and bronchial inflammation in asthmatic patients
Source: Eur Respir J 2002; 20: Suppl. 38, 49s
Year: 2002

Markers of airway inflammation and airway hyperresponsiveness remain stable in untreated asthmatics over time
Source: Annual Congress 2011 - Treatment strategies, systemic manifestations and biomarkers in airway diseases
Year: 2011

Involvement of airway eosinophilia and airway hyperresponsiveness in management and therapy for COPD>
Source: Virtual Congress 2020 – Clinical studies of COPD: combination inhalers and much more
Year: 2020

Increased airway closure is a determinant of airway hyperresponsiveness
Source: Eur Respir J 2008; 32: 1563-1569
Year: 2008



Airway hyperresponsiveness in obese and nonobese patients with cough-variant and bronchial asthma
Source: Annual Congress 2009 - Inflammation and airways
Year: 2009

Airway hyperresponsiveness in adult patients with and without allergies
Source: Virtual Congress 2021 – Lung function testing in the management of obstructive diseases
Year: 2021


Cholinergic tone and airway hyperresponsiveness in patients with persistent allergic asthma
Source: Eur Respir J 2006; 28: Suppl. 50, 219s
Year: 2006

Bronchial hyperreactivity and airway inflammatory markers in nonasthmatic rhinitis
Source: Eur Respir J 2003; 22: Suppl. 45, 476s
Year: 2003

Airway inflammation affects the perception of bronchoconstriction in asthma but not in CAO patients
Source: Eur Respir J 2003; 22: Suppl. 45, 417s
Year: 2003

Airway hyperresponsiveness with ΔFEV0.5 and ΔFEV0.75 in children
Source: Annual Congress 2010 - Phenotypes, mechanisms and diagnosis of asthma in childhood
Year: 2010

Upper and lower airway inflammation and bronchial hyperresponsiveness in allergic rhinitis children with or without asthma
Source: Annual Congress 2011 - Biological correlates and comorbidities of childhood asthma/allergy
Year: 2011